169 related articles for article (PubMed ID: 15357617)
1. A chiral synthesis of (-)-spiro[1-azabicyclo[2.2.2]octane-3,5'- oxazolidin-2'-one]: a conformationally restricted analogue of acetylcholine that is a potent and selective alpha7 nicotinic receptor agonist.
Macor JE; Mullen G; Verhoest P; Sampognaro A; Shepardson B; Mack RA
J Org Chem; 2004 Sep; 69(19):6493-5. PubMed ID: 15357617
[TBL] [Abstract][Full Text] [Related]
2. (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor.
Mullen G; Napier J; Balestra M; DeCory T; Hale G; Macor J; Mack R; Loch J; Wu E; Kover A; Verhoest P; Sampognaro A; Phillips E; Zhu Y; Murray R; Griffith R; Blosser J; Gurley D; Machulskis A; Zongrone J; Rosen A; Gordon J
J Med Chem; 2000 Nov; 43(22):4045-50. PubMed ID: 11063601
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of two fluoro analogues of the nicotinic acetylcholine receptor agonist UB-165.
Sutherland A; Gallagher T; Sharples CG; Wonnacott S
J Org Chem; 2003 Mar; 68(6):2475-8. PubMed ID: 12636420
[TBL] [Abstract][Full Text] [Related]
4. Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis.
Snoek SA; Verstege MI; van der Zanden EP; Deeks N; Bulmer DC; Skynner M; Lee K; Te Velde AA; Boeckxstaens GE; de Jonge WJ
Br J Pharmacol; 2010 May; 160(2):322-33. PubMed ID: 20423343
[TBL] [Abstract][Full Text] [Related]
5. Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice.
The FO; Boeckxstaens GE; Snoek SA; Cash JL; Bennink R; Larosa GJ; van den Wijngaard RM; Greaves DR; de Jonge WJ
Gastroenterology; 2007 Oct; 133(4):1219-28. PubMed ID: 17919496
[TBL] [Abstract][Full Text] [Related]
6. Activity of alpha7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes.
Papke RL; Porter Papke JK; Rose GM
Bioorg Med Chem Lett; 2004 Apr; 14(8):1849-53. PubMed ID: 15050614
[TBL] [Abstract][Full Text] [Related]
7. (R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.
Tatsumi R; Fujio M; Takanashi S; Numata A; Katayama J; Satoh H; Shiigi Y; Maeda J; Kuriyama M; Horikawa T; Murozono T; Hashimoto K; Tanaka H
J Med Chem; 2006 Jul; 49(14):4374-83. PubMed ID: 16821797
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.
Cook J; Zusi FC; McDonald IM; King D; Hill MD; Iwuagwu C; Mate RA; Fang H; Zhao R; Wang B; Cutrone J; Ma B; Gao Q; Knox RJ; Matchett M; Gallagher L; Ferrante M; Post-Munson D; Molski T; Easton A; Miller R; Jones K; Digavalli S; Healy F; Lentz K; Benitex Y; Clarke W; Natale J; Siuciak JA; Lodge N; Zaczek R; Denton R; Morgan D; Bristow LJ; Macor JE; Olson RE
J Med Chem; 2016 Dec; 59(24):11171-11181. PubMed ID: 27958732
[TBL] [Abstract][Full Text] [Related]
9. The selective alpha7 nicotinic acetylcholine receptor agonist AR-R17779 does not affect ischemia-reperfusion brain injury in mice.
Hammarlund ME; Darsalia V; Mjörnstedt F; Pattanaik B; Mallard C; Rocha-Ferreira E; Patrone C; Johansson ME
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34008839
[TBL] [Abstract][Full Text] [Related]
10. Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand.
Tatsumi R; Fujio M; Satoh H; Katayama J; Takanashi S; Hashimoto K; Tanaka H
J Med Chem; 2005 Apr; 48(7):2678-86. PubMed ID: 15801858
[TBL] [Abstract][Full Text] [Related]
11. AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
Levin ED; Bettegowda C; Blosser J; Gordon J
Behav Pharmacol; 1999 Nov; 10(6-7):675-80. PubMed ID: 10780509
[TBL] [Abstract][Full Text] [Related]
12. Suppression of abdominal aortic aneurysm formation by AR-R17779, an agonist for the α7 nicotinic acetylcholine receptor.
Watanabe A; Ichiki T; Kojima H; Takahara Y; Hurt-Camejo E; Michaëlsson E; Sankoda C; Ikeda J; Inoue E; Tokunou T; Kitamoto S; Sunagawa K
Atherosclerosis; 2016 Jan; 244():113-20. PubMed ID: 26613536
[TBL] [Abstract][Full Text] [Related]
13. Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
Ravert HT; Dorff P; Foss CA; Mease RC; Fan H; Holmquist CR; Phillips E; McCarthy DJ; Heys JR; Holt DP; Wang Y; Endres CJ; Dannals RF; Pomper MG
Nucl Med Biol; 2013 Aug; 40(6):731-9. PubMed ID: 23680470
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of α7 nicotinic acetylcholine receptor by AR-R17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice.
Hashimoto T; Ichiki T; Watanabe A; Hurt-Camejo E; Michaëlsson E; Ikeda J; Inoue E; Matsuura H; Tokunou T; Kitamoto S; Sunagawa K
Vascul Pharmacol; 2014; 61(2-3):49-55. PubMed ID: 24685818
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Δ2-isoxazoline derivatives as potent and selective agonists of α7 nicotinic acetylcholine receptors.
Dallanoce C; Magrone P; Matera C; Frigerio F; Grazioso G; De Amici M; Fucile S; Piccari V; Frydenvang K; Pucci L; Gotti C; Clementi F; De Micheli C
ChemMedChem; 2011 May; 6(5):889-903. PubMed ID: 21365765
[TBL] [Abstract][Full Text] [Related]
16. Conformationally constrained nicotines: polycyclic, bridged, and spiro-annulated analogues as novel ligands for the nicotinic acetylcholine receptor.
Ullrich T; Krich S; Binder D; Mereiter K; Anderson DJ; Meyer MD; Pyerin M
J Med Chem; 2002 Aug; 45(18):4047-54. PubMed ID: 12190326
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha7 selectivity.
Karig G; Large JM; Sharples CG; Sutherland A; Gallagher T; Wonnacott S
Bioorg Med Chem Lett; 2003 Sep; 13(17):2825-8. PubMed ID: 14611837
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective total synthesis of 1-epi-pathylactone A.
Chanu A; Safir I; Basak R; Chiaroni A; Arseniyadis S
Org Lett; 2007 Mar; 9(7):1351-4. PubMed ID: 17338539
[TBL] [Abstract][Full Text] [Related]
19. (+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptor.
Tatsumi R; Seio K; Fujio M; Katayama J; Horikawa T; Hashimoto K; Tanaka H
Bioorg Med Chem Lett; 2004 Jul; 14(14):3781-4. PubMed ID: 15203161
[TBL] [Abstract][Full Text] [Related]
20. Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity.
Acker BA; Jacobsen EJ; Rogers BN; Wishka DG; Reitz SC; Piotrowski DW; Myers JK; Wolfe ML; Groppi VE; Thornburgh BA; Tinholt PM; Walters RR; Olson BA; Fitzgerald L; Staton BA; Raub TJ; Krause M; Li KS; Hoffmann WE; Hajos M; Hurst RS; Walker DP
Bioorg Med Chem Lett; 2008 Jun; 18(12):3611-5. PubMed ID: 18490160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
